Previous 10 | Next 10 |
SOS (SOS) +36%.Titan Medical (TMDI) +25%.CBAK Energy Technology (CBAT) +21%.Altimeter Growth (AGCUU) +18%.CA Healthcare Acquisition (CAHCU) +16%.TransMedics (TMDX) +16%. as FDA Advisory Panel has issued a favorable vote in support of approval of the OCS Heart System.Altimeter Growth (AGC...
TransMedics (TMDX) announces that the FDA Advisory Panel has issued a favorable vote in support of approval of the OCS Heart System.The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks.With respect to reasonable assurance that the OCS Heart ...
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks PR Newswire ANDOVER, Mass. , April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasda...
TransMedics Group (TMDX) announced that NASDAQ has halted the trading of its common stock ahead of an FDA AdCom meeting scheduled for today at 9.00 AM EST to review its Organ Care System™ ("OCS") Heart System.The OCS™ Heart System is a device designed to preserve a don...
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System PR Newswire ANDOVER, Mass. , April 6, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX), a medical tech...
Gainers: [[CARA]] +10.5%. [[ILMN]] +10.4%. [[TMDX]] +6.0%. [[NTES]] +5.5%. [[HPK]] +4.7%.Losers: [[MDB]] -8.3%. [[RNA]] -7.4%. [[UCTT]] -6.9%. [[XELB]] -5.0%. [[PYPL]] -4.6%. For further details see: CARA, ILMN, MDB and RNA among after-hours movers
TransMedics Group, Inc. (TMDX) Q4 2020 Earnings Conference Call March 2, 2021 4:30 PM ET Company Participants Lynn Lewis – Investor Relations Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Dav...
TransMedics Group (TMDX): Q4 GAAP EPS of -$0.23 beats by $0.01.Revenue of $7.63M (+25.1% Y/Y) beats by $1.59M.Press Release For further details see: TransMedics Group EPS beats by $0.01, beats on revenue
TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire ANDOVER, Mass. , March 2, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ther...
NanoViricides (NNVC) +112% on effectiveness of COVID-19 drug candidates in cell culture studies.Communications Systems (JCS) +38% after entering merger agreement with Pineapple Energy.STRATA Skin Sciences (SSKN) +30% on announcing CEO Transition.CHF Solutions (CHFS) +25%.AgeX T...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
TransMedics Group Inc. Website:
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 PR Newswire ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant...
2024-07-04 23:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of TransMedics Group, Inc. (NASDAQ: TMDX) traded at a new 52-week high today and are currently trading at $139.5. So far today, approximately 249.23k shares have been exchanged, as compared to an average 30-day volume of 655.52k shares. TransMedics Group, Inc., a commercial-stage medic...